After comparing ALPROSTADIL with various PDE5 inhibitors, the researchers found that men who took PDE5 inhibitors for Ed as well as stability coronary artery disease not only reduced their risk of a new heart attack, and it increases life expectancy.
Read MoreThe U.S. Food and Drug Administration (FDA) on Thursday approved Bristol-Myers Squibb's (BMS) blockbuster PD-1 inhibitor Opdivo (nivolumab) in combination with chemotherapy as a first-line treatment for advanced or metastatic gastric cancer, gastroesophageal junction (GEJ) cancer and esophageal aden......
Read MoreWhen calcium carbonate is added to biodegradable plastics, the distance between polymers is increased by calcium carbonate particles, the force between polymer chain segments is weakened, and the re-crosslinking of macromolecular free radicals is hindered, which accelerates the free radical chain br......
Read More